This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: R.p.scherer Technologies, Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Danny Yu
Introduction
Danny Yu is an accomplished inventor based in Somerville, NJ (US). He has made significant strides in the field of pharmaceuticals, particularly in the development of oral solid dosage forms. His innovative approach combines the use of nanoparticles with fish gelatin, showcasing his commitment to advancing medical technology.
Latest Patents
Danny Yu holds a patent for an oral solid dosage form containing nanoparticles and the process of formulating the same using fish gelatin. This patent describes a method where the particle size of at least one pharmaceutically active ingredient is reduced in a solution containing fish gelatin to create a nanosuspension. The process is completed by freeze-drying the nanosuspension to produce the final oral solid dosage form. This innovative formulation has the potential to enhance drug delivery and efficacy.
Career Highlights
Danny Yu is currently employed at R.P. Scherer Technologies, Inc., where he continues to contribute to the field of pharmaceutical sciences. His work focuses on developing advanced drug delivery systems that can improve patient outcomes. With a patent portfolio that includes 1 patent, he is recognized for his contributions to the industry.
Collaborations
Danny collaborates with talented professionals in his field, including Deepak Bahl and Kieran James Crowley. These partnerships enhance the innovative capabilities of his projects and contribute to the success of their collective efforts.
Conclusion
Danny Yu's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the area of oral solid dosage forms, highlight the importance of research and development in improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
